Avid Bioservices Inc (CDMO)

[Threes]

Why, They don't need to stay on the Nasdaq.
They don't even deserve to be on the Nasdaq.
There are plenty of companies that trade multiples higher then PPHM trading OTC.

Down the road IF they deliver they will regain compliance ( remain over $1.00 ).
In the meantime they can save 200K a year in compliance fees and admin.

The Nasdaq issue is just cover for BOD to reset past dilution 225M OS down to a reasonable number so they can start the cycle over again and dilute the poop out of us.

Make them take a pay cut and run a cost effective manufacturing business.
Let MSK, NCCN, and AZN if they are so inclined do the R&D stuff, which history (30 years of it) shows is beyond their skill sets.

Back to 30 million outstanding after upcoming RS which will be back at 200 million within 18 months. While we shareholders will have 1/7th of our current holdings.

If this is in any way a positive for you then sleeping on a bed of nails probably seems like a good idea as well.